C. Ola Landgren, Leader, Translational and Clinical Oncology Program/Experimental Therapeutics at Sylvester Comprehensive Cancer Center, shared on LinkedIn:
“Miami brings people, ideas, and energy together. At the Sylvester Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami we are bringing that spirit to advancing myeloma care through innovation, excellence, and collaboration!
Last week in Coral Gables, we joined The Malcom Orlando Ivy Foundation and its founder, Michelle Ware-Ivy, Global Change Transformational Leader, together with Plexus Communications and its founder Kimberly Lynch, for an evening focused on earlier detection of multiple myeloma. The Foundations sponsored the program in collaboration with the Sylvester Myeloma Institute, bringing patient and caregiver experiences into conversation with clinical expertise.
Our moderator, Marsha Calloway-Campbell, guided the evening with warmth and purpose while sharing her experience as a caregiver. Michelle Ware-Ivy, Global Change Transformational Leader shared her own caregiver journey, and Sergio Jablon offered his perspective on living with multiple myeloma. Their stories reminded us why progress matters and who it must serve.
Dr. Joseph Mikhael discussed early myeloma, symptoms, and diagnostic evaluation. Dr. Katie Thoren explored laboratory and pathology findings, what may be missed in the early disease setting, and opportunities to improve detection. I had the pleasure of leading an interactive panel with Drs. Joseph Mikhael, Dickran Kazandjian, and Katie Thoren on early warning signs, laboratory abnormalities, and new horizons in detection and treatment.
Driving the field forward takes a community willing to ask better questions, share knowledge, and turn new ideas into meaningful improvements in care. It takes listening to patients and caregivers and building partnerships that connect discovery with everyday clinical practice.
That is the future we are working toward in Miami: earlier answers, more precise treatments, and better outcomes. Innovation gives us new possibilities. Excellence guides how we pursue them. Collaboration makes progress possible.
Thank you to Michelle Ware-Ivy, Global Change Transformational Leader, Marsha Calloway-Campbell, J.D., Sergio Jablon, Dickran Kazandjian, MD, Katie Thoren, and everyone who joined us.
The energy in Miami is unmistakable, and we are channeling it into a better future for people with multiple myeloma!”
You can also read: C. Ola Landgren: What Comes Next for Myeloma Research?
